Clinical Cancer Research, Vol 4, Issue 10 2411-2418, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck [published erratum appears in Clin Cancer Res 1999 Jan;5(1):222]

C Matthias, K Branigan, V Jahnke, K Leder, J Haas, J Heighway, PW Jones, RC Strange, AA Fryer and PR Hoban
Department of Otorhinolaryngology, Charite-Hospital, Humboldt-University, Berlin, Germany.

We have examined the correlation of a frequent A/G polymorphism within exon 4 of the cyclin D1 gene (CCND1) with genetic susceptibility and clinical outcome in 384 patients with squamous cell carcinoma (SCC) of the head and neck. CCND1 genotype frequencies were similar in the cases and 191 controls. Furthermore, the CCND1 genotype was not associated with susceptibility to SCC of the larynx, pharynx, or oral cavity. The influence of the CCND1 genotype on clinical outcome was also assessed. We found no correlation between genotype and tumor size (T1-T4), the involvement of nodes at presentation, or patient age and gender. However, the distribution of CCND1 genotypes in cases with poorly differentiated tumors was significantly different to that in patients with well-/moderately differentiated tumors (P = 0.016; chi2(2) = 8.71). Homozygosity for CCND1*G (GG genotype) was associated with poorly differentiated tumors (G3). We used Cox's proportional hazards model to investigate the influence of the CCND1 genotype on disease-free interval. CCND1 GG was associated with reduced disease-free interval [P = 0.001; hazard ratio (HR) = 2.95; 95% confidence interval (CI) = 1.54-5.63]. This remained significant after correction for tumor differentiation (P = 0.013; HR = 2.34; 95% CI = 1.2-4.6) and tumor stage (P = 0.005; HR = 2.64; 95% CI = 1.34-5.19). Analysis of the data from patients with tumors at different sites showed that the CCND1 GG genotype was associated with reduced disease-free interval in laryngeal (P = 0.004; HR = 3.63; 95% CI = 1.44-8.83) and pharyngeal (P = 0.006; HR = 3.48; 95% CI = 1.43-8.46) tumors. This is the first report of an association between CCND1 polymorphism and prognosis in SCC of the head and neck. These data show that the CCND1 GG genotype is an independent prognostic indicator of disease-free interval and supports initial observations in non-small cell lung cancer, that polymorphism within CCND1 influences tumor behavior.

This article has been cited by other articles:

				N. Pabalan, B. Bapat, L. Sung, H. Jarjanazi, O. Francisco-Pabalan, and H. Ozcelik Cyclin D1 Pro241Pro (CCND1-G870A) Polymorphism Is Associated with Increased Cancer Risk in Human Populations: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2773 - 2781. [Abstract] [Full Text] [PDF]

				C. J. Marsit, C. C. Black, M. R. Posner, and K. T. Kelsey A Genotype-Phenotype Examination of Cyclin D1 on Risk and Outcome of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., April 15, 2008; 14(8): 2371 - 2377. [Abstract] [Full Text] [PDF]

				J. Hopkins, D. W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, et al. Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 490 - 499. [Abstract] [Full Text] [PDF]

				H. Song, E. Hogdall, S. J. Ramus, R. A. DiCioccio, C. Hogdall, L. Quaye, V. McGuire, A. S. Whittemore, M. Shah, D. Greenberg, et al. Effects of Common Germ-Line Genetic Variation in Cell Cycle Genes on Ovarian Cancer Survival Clin. Cancer Res., February 15, 2008; 14(4): 1090 - 1095. [Abstract] [Full Text] [PDF]

				A. Gurlek, N. Karavitaki, O. Ansorge, and J. A H Wass What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics Eur. J. Endocrinol., February 1, 2007; 156(2): 143 - 153. [Abstract] [Full Text] [PDF]

				M. R. Spitz, X. Wu, and G. Mills Integrative Epidemiology: From Risk Assessment to Outcome Prediction J. Clin. Oncol., January 10, 2005; 23(2): 267 - 275. [Abstract] [Full Text] [PDF]

				X. O. Shu, D. B. Moore, Q. Cai, J. Cheng, W. Wen, L. Pierce, H. Cai, Y.-T. Gao, and W. Zheng Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 91 - 97. [Abstract] [Full Text] [PDF]

				S. Qiuling, Z. Yuxin, Z. Suhua, X. Cheng, L. Shuguang, and H. Fengsheng Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population Carcinogenesis, September 1, 2003; 24(9): 1499 - 1503. [Abstract] [Full Text] [PDF]

				J. G. Izzo, V. A. Papadimitrakopoulou, D. D. Liu, P. L. C. den Hollander, I. M. Babenko, J. Keck, A. K. El-Naggar, D. M. Shin, J. J. Lee, W. K. Hong, et al. Cyclin D1 Genotype, Response to Biochemoprevention, and Progression Rate to Upper Aerodigestive Tract Cancer J Natl Cancer Inst, February 5, 2003; 95(3): 198 - 205. [Abstract] [Full Text] [PDF]

				L. Wang, T. Habuchi, T. Takahashi, K. Mitsumori, T. Kamoto, Y. Kakehi, H. Kakinuma, K. Sato, A. Nakamura, O. Ogawa, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer Carcinogenesis, February 1, 2002; 23(2): 257 - 264. [Abstract] [Full Text] [PDF]

				D.J. Simpson, A.A. Fryer, A.B. Grossman, J.A.H. Wass, M. Pfeifer, J.M. Kros, R.N. Clayton, and W.E. Farrell Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas Carcinogenesis, November 1, 2001; 22(11): 1801 - 1807. [Abstract] [Full Text] [PDF]

				S. L. Holley, G. Parkes, C. Matthias, U. Bockmuhl, V. Jahnke, K. Leder, R. C. Strange, A. A. Fryer, and P. R. Hoban Cyclin D1 Polymorphism and Expression in Patients with Squamous Cell Carcinoma of the Head and Neck Am. J. Pathol., November 1, 2001; 159(5): 1917 - 1924. [Abstract] [Full Text] [PDF]

				Y. Zheng, H. Shen, E. M. Sturgis, L.-E Wang, S. A. Eicher, S. S. Strom, M. L. Frazier, M. R. Spitz, and Q. Wei Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study Carcinogenesis, August 1, 2001; 22(8): 1195 - 1199. [Abstract] [Full Text] [PDF]

				S. Kong, C. I. Amos, R. Luthra, P. M. Lynch, B. Levin, and M. L. Frazier Effects of Cyclin D1 Polymorphism on Age of Onset of Hereditary Nonpolyposis Colorectal Cancer Cancer Res., January 1, 2000; 60(2): 249 - 252. [Abstract] [Full Text]

				C. Matthias, V. Jahnke, P. W. Jones, P. R. Hoban, J. E. Alldersea, S. F. Worrall, A. A. Fryer, and R. C. Strange Cyclin D1, Glutathione S-Transferase, and Cytochrome P450 Genotypes and Outcome in Patients with Upper Aerodigestive Tract Cancers: Assessment of the Importance of Individual Genes Using Multivariate Analysis Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 815 - 823. [Abstract] [Full Text]